GYRE Earnings GYRE THERAPEUTICS, INC.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–36 of 36
| Q2 2026 | 2026-06-30 | -0.26 | 2026-08-07 | 10-Q |
| Q1 2026 | 2026-03-31 | -0.10 | 2026-05-08 | 10-Q |
| FY 2025 | 2025-12-31 | 0.02 | 2026-03-13 | 10-K |
| Q3 2025 | 2025-09-30 | 0.04 | 2025-11-07 | 10-Q |
| Q2 2026 | 2025-06-30 | -0.03 | 2026-08-07 | 10-Q |
| Q1 2026 | 2025-03-31 | 0.00 | 2026-05-08 | 10-Q |
| FY 2025 | 2024-12-31 | 0.05 | 2026-03-13 | 10-K |
| Q3 2025 | 2024-09-30 | 0.05 | 2025-11-07 | 10-Q |
| Q2 2025 | 2024-06-30 | 0.04 | 2025-08-11 | 10-Q |
| Q1 2025 | 2024-03-31 | 0.03 | 2025-05-09 | 10-Q |
| FY 2024 | 2023-12-31 | -1.41 | 2025-03-17 | 10-K |
| Q3 2024 | 2023-09-30 | 0.10 | 2024-11-13 | 10-Q |
| Q2 2024 | 2023-06-30 | 0.05 | 2024-08-13 | 10-Q |
| Q1 2024 | 2023-03-31 | 0.03 | 2024-05-13 | 10-Q |
| FY 2023 | 2022-12-31 | 0.03 | 2024-03-27 | 10-K |
| Q3 2023 | 2022-09-30 | 1.02 | 2023-10-26 | 10-Q |
| Q2 2023 | 2022-06-30 | 1.18 | 2023-08-14 | 10-Q |
| Q1 2023 | 2022-03-31 | -0.46 | 2023-05-15 | 10-Q |
| FY 2022 | 2021-12-31 | -2.87 | 2023-03-30 | 10-K |
| Q3 2022 | 2021-09-30 | -2.23 | 2022-11-14 | 10-Q |
| Q2 2022 | 2021-06-30 | -1.42 | 2022-08-15 | 10-Q |
| Q3 2013 | 2013-09-30 | -0.99 | 2013-11-06 | 10-Q |
| Q2 2013 | 2013-06-30 | -0.61 | 2013-08-07 | 10-Q |
| Q1 2013 | 2013-03-31 | -0.24 | 2013-05-08 | 10-Q |
| FY 2013 | 2012-12-31 | -0.47 | 2014-03-14 | 10-K |
| FY 2013 | 2012-09-30 | -0.24 | 2014-03-14 | 10-K |
| FY 2013 | 2012-06-30 | 0.43 | 2014-03-14 | 10-K |
| FY 2013 | 2012-03-31 | 0.07 | 2014-03-14 | 10-K |
| FY 2012 | 2011-12-31 | -0.27 | 2013-03-15 | 10-K |
| FY 2012 | 2011-09-30 | -0.27 | 2013-03-15 | 10-K |
| FY 2012 | 2011-06-30 | -0.07 | 2013-03-15 | 10-K |
| FY 2012 | 2011-03-31 | 0.41 | 2013-03-15 | 10-K |
| FY 2012 | 2010-12-31 | 0.36 | 2013-03-15 | 10-K |
| Q3 2011 | 2010-09-30 | 0.43 | 2011-11-03 | 10-Q |
| Q2 2011 | 2010-06-30 | 0.35 | 2011-08-09 | 10-Q |
| FY 2011 | 2009-12-31 | -1.54 | 2012-03-06 | 10-K |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.